{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:34:51Z","timestamp":1769121291655,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T00:00:00Z","timestamp":1439510400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006546","name":"Angelini","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006546","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s11739-015-1288-3","type":"journal-article","created":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T10:45:08Z","timestamp":1439462708000},"page":"49-59","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Non-steroidal anti-inflammatory drugs and risk of cerebrovascular events in patients with osteoarthritis: a nested case\u2013control study"],"prefix":"10.1007","volume":"11","author":[{"given":"Francesco","family":"Lapi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Piccinni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Levi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierangelo","family":"Lora Aprile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iacopo","family":"Cricelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Cricelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,14]]},"reference":[{"issue":"Suppl 1","key":"1288_CR1","first-page":"S29","volume":"14","author":"J Deviere","year":"2002","unstructured":"Deviere J (2002) Do selective cyclo-oxygenase inhibitors eliminate the adverse events associated with nonsteroidal anti-inflammatory drug therapy? Eur J Gastroenterol Hepatol 14(Suppl 1):S29\u2013S33","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1288_CR2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00002018-200427070-00002","volume":"27","author":"DW Clark","year":"2004","unstructured":"Clark DW, Layton D, Shakir SA (2004) Do some inhibitors of COX-2 increase the risk of thromboembolic events? Linking pharmacology with pharmacoepidemiology. Drug Saf 27:427\u2013456","journal-title":"Drug Saf"},{"key":"1288_CR3","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","volume":"352","author":"RS Bresalier","year":"2005","unstructured":"Bresalier RS, Sandler RS, Quan H et al (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352:1092\u20131102. doi: 10.1056\/NEJMoa050493","journal-title":"N Engl J Med"},{"key":"1288_CR4","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(08)61490-7","volume":"372","author":"JA Baron","year":"2008","unstructured":"Baron JA, Sandler RS, Bresalier RS et al (2008) Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial. Lancet 372:1756\u20131764. doi: 10.1016\/S0140-6736(08)61490-7","journal-title":"Lancet"},{"key":"1288_CR5","unstructured":"EMA (2012) Review of non-selective non-steroidal anti-inflammatory drugs (NSAIDs) and cardiovascular risk. Outcome of a procedure under Article 5(3) of Regulation (EC) No 726\/20041"},{"key":"1288_CR6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/pds.3437","volume":"22","author":"C Varas-Lorenzo","year":"2013","unstructured":"Varas-Lorenzo C, Riera-Guardia N, Calingaert B et al (2013) Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies. Pharmacoepidemiol Drug Saf 22:559\u2013570. doi: 10.1002\/pds.3437","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1288_CR7","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jacc.2008.08.041","volume":"52","author":"LA Garcia Rodriguez","year":"2008","unstructured":"Garcia Rodriguez LA, Tacconelli S, Patrignani P (2008) Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population. J Am Coll Cardiol 52:1628\u20131636. doi: 10.1016\/j.jacc.2008.08.041","journal-title":"J Am Coll Cardiol"},{"key":"1288_CR8","volume-title":"Risk of nonfatal acute myocardial infarction associated with non-steroidal antiinflammatory drugs, non-narcotic analgesics and other drugs used in osteoarthritis: a nested case-control study","author":"FJ Abajo De","year":"2014","unstructured":"De Abajo FJ, Gil MJ, Garc\u00eda Poza P et al (2014) Risk of nonfatal acute myocardial infarction associated with non-steroidal antiinflammatory drugs, non-narcotic analgesics and other drugs used in osteoarthritis: a nested case-control study. Pharmacoepidemiol, Drug Saf. doi: 10.1002\/pds.3617"},{"issue":"5","key":"1288_CR9","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/jth.12855","volume":"13","author":"P Garc\u00eda-Poza","year":"2015","unstructured":"Garc\u00eda-Poza P, de Abajo FJ, Gil MJ et al (2015) Risk of ischaemic stroke associated with non-steroidal antiinflammatory drugs and paracetamol: a population-based case-control study. J Thromb Haemost 13(5):708\u2013718","journal-title":"J Thromb Haemost"},{"key":"1288_CR10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/CIRCOUTCOMES.109.861104","volume":"3","author":"EL Fosbol","year":"2010","unstructured":"Fosbol EL, Folke F, Jacobsen S et al (2010) Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals. Circ Cardiovasc Qual Outcomes 3:395\u2013405. doi: 10.1161\/circoutcomes.109.861104","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"1288_CR11","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/pds.2227","volume":"20","author":"C Varas-Lorenzo","year":"2011","unstructured":"Varas-Lorenzo C, Riera-Guardia N, Calingaert B et al (2011) Stroke risk and NSAIDs: a systematic review of observational studies. Pharmacoepidemiol Drug Saf 20:1225\u20131236. doi: 10.1002\/pds.2227","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1288_CR12","unstructured":"Gruppo di lavoro OsMed. L'uso dei farmaci in Italia. Rapporto nazionale anno 2011. Roma: Il Pensiero Scientifico Editore, 2012"},{"key":"1288_CR13","unstructured":"Piccoliori G Turbil E, Pecchioli S, Sessa E, Cancian M, Lora Aprile P (2007) Italian Pain Research: dati preliminari di una ricerca osservazionale in medicina generale. Riv SIMG:6\u201311"},{"key":"1288_CR14","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/rheumatology\/keu403","volume":"54","author":"N Wilson","year":"2015","unstructured":"Wilson N, Sanchez-Riera L, Morros R et al (2015) Drug utilization in patients with OA: a population-based study. Rheumatology 54:860\u2013867. doi: 10.1093\/rheumatology\/keu403","journal-title":"Rheumatology"},{"key":"1288_CR15","author":"MM Rahman","year":"2013","unstructured":"Rahman MM, Kopec JA, Anis AH et al (2013) The risk of cardiovascular disease in patients with osteoarthritis: a prospective longitudinal study. Arthritis Care Res. doi: 10.1002\/acr.22092","journal-title":"Arthritis Care Res"},{"key":"1288_CR16","author":"MM Rahman","year":"2013","unstructured":"Rahman MM, Kopec JA, Cibere J et al (2013) The relationship between osteoarthritis and cardiovascular disease in a population health survey: a cross-sectional study. BMJ Open. doi: 10.1136\/bmjopen-2013-002624","journal-title":"BMJ Open"},{"key":"1288_CR17","author":"PM Coloma","year":"2013","unstructured":"Coloma PM, Valkhoff VE, Mazzaglia G et al (2013) Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries. BMJ Open. doi: 10.1136\/bmjopen-2013-002862","journal-title":"BMJ Open"},{"key":"1288_CR18","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1183\/09031936.00128713","volume":"42","author":"C Sterrantino","year":"2013","unstructured":"Sterrantino C, Trifiro G, Lapi F et al (2013) Burden of community-acquired pneumonia in Italian general practice. Eur Respir J 42:1739\u20131742. doi: 10.1183\/09031936.00128713","journal-title":"Eur Respir J"},{"key":"1288_CR19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/annrheumdis-2011-201254","volume":"72","author":"G Trifiro","year":"2013","unstructured":"Trifiro G, Morabito P, Cavagna L et al (2013) Epidemiology of gout and hyperuricaemia in Italy during the years 2005\u20132009: a nationwide population-based study. Ann Rheum Dis 72:694\u2013700. doi: 10.1136\/annrheumdis-2011-201254","journal-title":"Ann Rheum Dis"},{"key":"1288_CR20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bone.2011.09.048","volume":"50","author":"F Lapi","year":"2012","unstructured":"Lapi F, Simonetti M, Michieli R et al (2012) Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care. Bone 50:85\u201390. doi: 10.1016\/j.bone.2011.09.048","journal-title":"Bone"},{"key":"1288_CR21","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.108.830299","volume":"120","author":"G Mazzaglia","year":"2009","unstructured":"Mazzaglia G, Ambrosioni E, Alacqua M et al (2009) Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 120:1598\u20131605. doi: 10.1161\/CIRCULATIONAHA.108.830299","journal-title":"Circulation"},{"key":"1288_CR22","first-page":"49","volume":"6","author":"A Filippi","year":"2005","unstructured":"Filippi A, Vanuzzo D, Bignamini AA et al (2005) Computerized general practice databases provide quick and cost-effective information on the prevalence of angina pectoris. Ital Heart J 6:49\u201351","journal-title":"Ital Heart J"},{"key":"1288_CR23","unstructured":"Bianchini E, Brignoli O, Cricelli C et al (2014) VIII Report Health Search. Anno 2013\/2014. Firenze"},{"key":"1288_CR24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/01621459.1996.10476660","volume":"91","author":"NE Breslow","year":"1996","unstructured":"Breslow NE (1996) Statistics in epidemiology: the case-control study. J Am Stat Assoc 91:14\u201328","journal-title":"J Am Stat Assoc"},{"key":"1288_CR25","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/oxfordjournals.aje.a009758","volume":"149","author":"M Salas","year":"1999","unstructured":"Salas M, Hofman A, Stricker BH (1999) Confounding by indication: an example of variation in the use of epidemiologic terminology. Am J Epidemiol 149:981\u2013983. doi: 10.1093\/oxfordjournals.aje.a009758","journal-title":"Am J Epidemiol"},{"key":"1288_CR26","author":"GA Hawker","year":"2014","unstructured":"Hawker GA, Croxford R, Bierman AS et al (2014) All-cause mortality and serious cardiovascular events in people with hip and knee osteoarthritis: a population based cohort study. PLoS One. doi: 10.1371\/journal.pone.0091286","journal-title":"PLoS One"},{"key":"1288_CR27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/EDE.0000000000000221","volume":"26","author":"S Suissa","year":"2015","unstructured":"Suissa S (2015) The Quasi-cohort approach in pharmacoepidemiology. Epidemiology 26:242\u2013246. doi: 10.1097\/EDE.0000000000000221","journal-title":"Epidemiology"},{"key":"1288_CR28","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.296.13.jrv60011","volume":"296","author":"P McGettigan","year":"2006","unstructured":"McGettigan P, Henry D (2006) Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 296:1633\u20131644. doi: 10.1016\/S0093-3619(08)70535-5","journal-title":"JAMA"},{"key":"1288_CR29","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/STROKEAHA.114.007932","volume":"46","author":"S-Y Chuang","year":"2015","unstructured":"Chuang S-Y, Yu Y, Huey-Herng Sheu W et al (2015) Association of short-term use of nonsteroidal anti-inflammatory drugs with stroke in patients with hypertension. Stroke 46:996\u20131003. doi: 10.1161\/STROKEAHA.114.007932","journal-title":"Stroke"},{"key":"1288_CR30","first-page":"25","volume":"10","author":"K Park","year":"2014","unstructured":"Park K, Bavry AA (2014) Risk of stroke associated with nonsteroidal anti-inflammatory drugs. Vasc Heal Risk Manag 10:25\u201332. doi: 10.2147\/vhrm.s54159","journal-title":"Vasc Heal Risk Manag"},{"key":"1288_CR31","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1212\/01.wnl.0000233981.26176.e1","volume":"67","author":"TS Bowman","year":"2006","unstructured":"Bowman TS, Gaziano JM, Kase CS et al (2006) Blood pressure measures and risk of total, ischemic, and hemorrhagic stroke in men. Neurology 67:820\u2013823. doi: 10.1212\/01.wnl.0000233981.26176.e1","journal-title":"Neurology"},{"key":"1288_CR32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archinte.1993.00410040045007","volume":"153","author":"JE Pope","year":"1993","unstructured":"Pope JE, Anderson JJ, Felson DT (1993) A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 153:477\u2013484. doi: 10.1001\/archinte.1993.00410040045007","journal-title":"Arch Intern Med"},{"key":"1288_CR33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/0003-4819-121-4-199408150-00011","volume":"121","author":"AG Johnson","year":"1994","unstructured":"Johnson AG, Nguyen TV, Day RO (1994) Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 121:289\u2013300. doi: 10.7326\/0003-4819-121-4-199408150-00011","journal-title":"Ann Intern Med"},{"key":"1288_CR34","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0022-3565(24)38776-2","volume":"296","author":"D Riendeau","year":"2001","unstructured":"Riendeau D, Percival MD, Brideau C et al (2001) Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther 296:558\u2013566","journal-title":"J Pharmacol Exp Ther"},{"key":"1288_CR35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-2999(01)01207-9","volume":"426","author":"F Giuliano","year":"2001","unstructured":"Giuliano F, Ferraz JGP, Pereira R et al (2001) Cyclooxygenase selectivity of non-steroid anti-inflammatory drugs in humans: ex vivo evaluation. Eur J Pharmacol 426:95\u2013103. doi: 10.1016\/S0014-2999(01)01207-9","journal-title":"Eur J Pharmacol"},{"key":"1288_CR36","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","volume":"96","author":"TD Warner","year":"1999","unstructured":"Warner TD, Giuliano F, Vojnovic I et al (1999) Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci 96:7563\u20137568","journal-title":"Proc Natl Acad Sci"},{"key":"1288_CR37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s000110050221","volume":"46","author":"JP Famaey","year":"1997","unstructured":"Famaey JP (1997) In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview. Inflamm Res 46:437\u2013446","journal-title":"Inflamm Res"},{"key":"1288_CR38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s10787-006-1505-9","volume":"14","author":"KD Rainsford","year":"2006","unstructured":"Rainsford KD (2006) Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide. Inflammopharmacology 14:120\u2013137. doi: 10.1007\/s10787-006-1505-9","journal-title":"Inflammopharmacology"},{"key":"1288_CR39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1472-8206.2011.00991.x","volume":"27","author":"M Lapeyre-Mestre","year":"2013","unstructured":"Lapeyre-Mestre M, Grolleau S, Montastruc JL (2013) Adverse drug reactions associated with the use of NSAIDs: a case\/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002-2006. Fundam Clin Pharmacol 27:223\u2013230. doi: 10.1111\/j.1472-8206.2011.00991.x","journal-title":"Fundam Clin Pharmacol"},{"key":"1288_CR40","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1111\/j.1538-7836.2007.02782.x","volume":"5","author":"J Graff","year":"2007","unstructured":"Graff J, Skarke C, Klinkhardt U et al (2007) Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteers. J Thromb Haemost 5:2376\u20132385. doi: 10.1111\/j.1538-7836.2007.02782.x","journal-title":"J Thromb Haemost"},{"key":"1288_CR41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1747-4949.2011.00594.x","volume":"6","author":"S Sacco","year":"2011","unstructured":"Sacco S, Stracci F, Cerone D et al (2011) Epidemiology of stroke in Italy. Int J Stroke 6:219\u2013227. doi: 10.1111\/j.1747-4949.2011.00594.x","journal-title":"Int J Stroke"},{"key":"1288_CR42","unstructured":"Istituto Superiore di Sanit\u00e0. Progetto CUORE\u2014Epidemiology and prevention of ischaemic heart diseases. http:\/\/www.cuore.iss.it\/indicatori\/popolazione.asp . Accessed 26 June 2015"},{"key":"1288_CR43","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/ije\/dyi184","volume":"34","author":"MP Fox","year":"2005","unstructured":"Fox MP, Lash TL, Greenland S (2005) A method to automate probabilistic sensitivity analyses of misclassified binary variables. Int J Epidemiol 34:1370\u20131376. doi: 10.1093\/ije\/dyi184","journal-title":"Int J Epidemiol"},{"key":"1288_CR44","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/pds.1454","volume":"16","author":"MU Yood","year":"2007","unstructured":"Yood MU, Campbell UB, Rothman KJ et al (2007) Using prescription claims data for drugs available over-the-counter (OTC). Pharmacoepidemiol Drug Saf 16:961\u2013968. doi: 10.1002\/pds.1454","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1288_CR45","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/01.STR.0000226642.55207.94","volume":"37","author":"F Andersohn","year":"2006","unstructured":"Andersohn F, Schade R, Suissa S et al (2006) Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study. Stroke 37:1725\u20131730. doi: 10.1161\/01.STR.0000226642.55207.94","journal-title":"Stroke"},{"key":"1288_CR46","author":"F Salvo","year":"2014","unstructured":"Salvo F, Antoniazzi S, Duong M et al (2014) Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studies. Expert Opin Drug Saf. doi: 10.1517\/14740338.2014.907792","journal-title":"Expert Opin Drug Saf"},{"key":"1288_CR47","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/oxfordjournals.aje.a116398","volume":"135","author":"S Wacholder","year":"1992","unstructured":"Wacholder S, Silverman DT, McLaughlin JK et al (1992) Selection of controls in case-control studies. III. Design options. Am J Epidemiol 135:1042\u20131050","journal-title":"Am J Epidemiol"},{"key":"1288_CR48","unstructured":"Farmadati Italia. http:\/\/www.farmadati.it\/ . Accessed 19 June 2015"},{"key":"1288_CR49","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00001648-199205000-00005","volume":"3","author":"P Kristensen","year":"1992","unstructured":"Kristensen P (1992) Bias from nondifferential but dependent misclassification of exposure and outcome. Epidemiology 3:210\u2013215. doi: 10.1097\/00001648-199205000-00005","journal-title":"Epidemiology"},{"key":"1288_CR50","unstructured":"Italian Medicines Agency (2012) Note number 66 on the prescription of nonsteroidal anti-inflammatory drug. Italy"},{"key":"1288_CR51","doi-asserted-by":"crossref","first-page":"e8525","DOI":"10.1136\/bmj.e8525","volume":"346","author":"F Lapi","year":"2013","unstructured":"Lapi F, Azoulay L, Yin H et al (2013) Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ 346:e8525. doi: 10.1136\/bmj.e8525","journal-title":"BMJ"},{"key":"1288_CR52","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7326\/M14-1231","volume":"162","author":"RR Bannuru","year":"2015","unstructured":"Bannuru RR, Schmid CH, Kent DM et al (2015) Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med 162:46\u201354. doi: 10.7326\/M14-1231","journal-title":"Ann Intern Med"},{"key":"1288_CR53","first-page":"671","volume-title":"Goodman & Gilman's The pharmacological basis of therapeutics","author":"A Burke","year":"2006","unstructured":"Burke A, Smyth EM, Fitzgerald GA (2006) Analgesic-antipyretic agents: pharmacotherapy of gout. In: Brunton LL, Lazo JS, Parker KL (eds) Goodman & Gilman's The pharmacological basis of therapeutics, 11th edn. Mc Graw-Hill, New York, p 671-715","edition":"11"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-015-1288-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-015-1288-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-015-1288-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:06:44Z","timestamp":1748563604000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-015-1288-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,14]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["1288"],"URL":"https:\/\/doi.org\/10.1007\/s11739-015-1288-3","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,14]]}}}